BNC210, an α7 Nicotinic Receptor Modulator, in Post-Traumatic Stress Disorder
NEJM Evidence · 2025-01 · 4 (1)
DOI: 10.1056/evidoa2400380 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift NEJM Evidence, 2025-01. Verfasst von Spyridon Papapetropoulos und 7 weiteren Autor:innen. Beteiligte Einrichtung: Bionomics Limited, Adelaide, SA, Australia. Hauptthemen laut MEDLINE: Stress Disorders, Post-Traumatic, alpha7 Nicotinic Acetylcholine Receptor. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Bionomics Limited, Adelaide, SA, Australia.
- Summit Analytical, Denver.
- Clinical Pharmacology Consulting and University of Adelaide Medical School, Adelaide, SA, Australia.
- Department of Psychiatry and School of Public Health, University of California, San Diego, La Jolla.
Zitieren
APA
Papapetropoulos, S., Doolin, E., O'Connor, S., Paul, D., Odontiadis, M., Jaros, M., Rolan, P., & Stein, M. B. (2025). BNC210, an α7 Nicotinic Receptor Modulator, in Post-Traumatic Stress Disorder. NEJM Evidence, 4(1). https://doi.org/10.1056/evidoa2400380
Vancouver
Papapetropoulos S, Doolin E, O'Connor S, Paul D, Odontiadis M, Jaros M, et al. BNC210, an α7 Nicotinic Receptor Modulator, in Post-Traumatic Stress Disorder. NEJM Evidence. 2025;4(1). doi:10.1056/evidoa2400380
BibTeX
@article{Papapetropoulos2025,
author = {Papapetropoulos, Spyridon and Doolin, Elizabeth and O'Connor, Susan and Paul, Dharam and Odontiadis, Michael and Jaros, Mark and Rolan, Paul and Stein, Murray B},
title = {BNC210, an α7 Nicotinic Receptor Modulator, in Post-Traumatic Stress Disorder},
journal = {NEJM Evidence},
year = {2025},
volume = {4},
number = {1},
doi = {10.1056/evidoa2400380}
}
EUVIMED